The tumor types of these responders were estrogen receptor positive breast cancer, cervical cancer and KRAS-mutant colon cancer, and PIK3CA mutations were detected in all three cases (E542K/V, E545K and R88Q respectively). Here, KRAS is linked to malignant colon neoplasm.